Mayfair Advisory Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Mayfair Advisory Group's LLY Position: Q3 2026 in Review
Mayfair Advisory Group increased its Eli Lilly (LLY) stake by 4.7% in Q3 2026, buying an estimated $74.3K and bringing the position to 1,414 shares worth $1.64M. The position accounts for 0.47% of the portfolio, ranked #42.
Mayfair Advisory Group first reported a position in LLY in Q2 2020 and has held it in 26 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Mayfair Advisory Group held 1,414 shares of Eli Lilly worth $1.64M as of Q3 2026.
- Mayfair Advisory Group bought 63 Eli Lilly shares in Q3 2026, an estimated $74.3K.
- Eli Lilly made up 0.47% of Mayfair Advisory Group's portfolio in Q3 2026, its #42 holding.
- Mayfair Advisory Group first reported a position in Eli Lilly in Q2 2020 and has held it in 26 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Mayfair Advisory Group's 13F filing for Q3 2026, filed 20 Oct 2026.